Computer-aided design of carbon nanotubes with the desired bioactivity and safety profiles

References

• Arts JHE, Muijser H, Jonker D, Van De Sandt JJM, Bos PMJ, Feron VJ. 2008. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments. Exp Toxicol Pathol 60:125–33
   PubMed Web of Science ®Google Scholar
• Austin CP. 2009. The Tox21 collaboration on predictive toxicology the best of times, the worst of times. Toxicology 112:385–93
   Web of Science ®Google Scholar
• Baalousha M, Lead JR. 2013. Nanoparticle dispersity in toxicology. Nat Nanotechnol 8:308–9
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang Y, Zhang J, Mu Q, Zhang W, Butch ER, et al. 2010. Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility. Nat Nanotechnol 5:683–9
   PubMed Web of Science ®Google Scholar
• Breiman L. 2001. Random forests. Mach Learn 45:5–32
   Web of Science ®Google Scholar
• Burello E, Worth A. 2011. Computational nanotoxicology: predicting toxicity of nanoparticles. Nat Nanotechnol 6:138–9
   PubMed Web of Science ®Google Scholar
• Carbó-Dorca R, Besalú E. 2011. Construction of coherent nano quantitative structure–properties relationships (nano-QSPR) models and catastrophe theory. SAR QSAR Environ Res 22:661–5
   PubMed Web of Science ®Google Scholar
• Chandana Epa V, Burden FR, Tassa C, Weissleder R, Shaw S. 2012. Modeling biological activities of nanoparticles. Nano Lett 12:5808–12
   PubMed Web of Science ®Google Scholar
• Chau YT, Yap CW. 2012. Quantitative nanostructure–activity relationship modelling of nanoparticles. RSC Adv 2:8489–96
   Web of Science ®Google Scholar
• Cristianini N, Shawe-Taylor J. 2000. An Introduction to Support Vector Machines, History. Cambridge, MA: Cambridge University Press
   Google Scholar
• Demirdjian ZS. 2006. Nanotechnology: The New Frontier for Business and Industry. J Am Acad Bus Cambridge 8:I–II
   Google Scholar
• Downs GM, Barnard JM. 2002. Clustering methods and their uses in computational chemistry. Rev Comput Chem 18:1–40
   Web of Science ®Google Scholar
• European Parliament EC. 2010. REACH regulation. [Online] Available at http://ec.europa.eu/enterprise/sectors/chemicals/reach/index_en.htm. Accessed on 7 January 2014
   Google Scholar
• Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A. 2010a. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol 23:171–83
   PubMed Web of Science ®Google Scholar
• Fourches D, Muratov E, Tropsha A. 2010b. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50:1189–204
   PubMed Web of Science ®Google Scholar
• Fourches D, Pu D, Tassa C, Weissleder R, Shaw SY, Mumper RJ, Tropsha A. 2010c. Quantitative nanostructure–activity relationship modeling. ACS Nano 4:5703–12
   PubMed Web of Science ®Google Scholar
• Fourches D, Pu D, Tropsha A. 2011. Exploring quantitative nanostructure–activity relationships (QNAR) modeling as a tool for predicting biological effects of manufactured nanoparticles. Comb Chem High Throughput Screen 14:217–25
   PubMed Web of Science ®Google Scholar
• Gajewicz A, Schaeublin N, Rasulev B, Hussain S, Leszczynska D, Puzyn T, Leszczynski J. 2015. Towards understanding mechanisms governing cytotoxicity of metal oxides nanoparticles: hints from nano-QSAR studies. Nanotoxicology 9:313–25
   PubMed Web of Science ®Google Scholar
• Ghorbanzadeh M, Fatemi MH, Karimpour M. 2012. Modeling the cellular uptake of magnetofluorescent nanoparticles in pancreatic cancer cells: a quantitative structure activity relationship study. Ind Eng Chem Res 51:10712–18
   Web of Science ®Google Scholar
• Hartung T. 2010. Evidence-based toxicology – the toolbox of validation for the 21st century? ALTEX Altern zu Tierexperimenten 27:253–63
   PubMed Web of Science ®Google Scholar
• Jastrzębska AM, Kurtycz P, Olszyna AR. 2012. Recent advances in graphene family materials toxicity investigations. J Nanopart Res 14:1320–8
   PubMed Web of Science ®Google Scholar
• Jones R. 2009. Nanotechnology, energy and markets. Nat Nanotechnol 4:doi:10.1038/nnano.2008.420
   Web of Science ®Google Scholar
• Kaiser J-P, Krug HF, Wick P. 2009. Nanomaterial cell interactions: how do carbon nanotubes affect cell physiology? Nanomedicine 4:57–63
   PubMed Web of Science ®Google Scholar
• Kar S, Gajewicz A, Puzyn T, Roy K. 2014. Nano-quantitative structure–activity relationship modeling using easily computable and interpretable descriptors for uptake of magnetofluorescent engineered nanoparticles in pancreatic cancer cells. Toxicol In Vitro 28:600–6
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar P, Anandan A, Fernandes TF, Ayoko GA, Biskos G. 2014. Engineered nanomaterials: knowledge gaps in fate, exposure, toxicity, and future directions. J Nanomater 2014:1–16
   Google Scholar
• Liu Y, Hayes DN, Nobel A, Marron JS. 2008. Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 103:1281–93
   Web of Science ®Google Scholar
• Luan F, Kleandrova VV, González-Díaz H, Ruso JM, Melo A, Speck-Planche A, Cordeiro MNDS. 2014. Computer-aided nanotoxicology: assessing cytotoxicity of nanoparticles under diverse experimental conditions by using a novel QSTR-perturbation approach. Nanoscale 6:10623–30
   PubMed Web of Science ®Google Scholar
• Luther W. 2004. Industrial application of nanomaterials – chances and risks, technology analysis. Dusseldorf: Future Technologies Division of VDI Technologiezentrum Germany. Available at http://www.innovationsbegleitung.de/11.pdf. Accessed on 7 January 2014
   Google Scholar
• Mauri A, Consonni V, Pavan M, Todeschini R. 2006. Dragon software: an easy approach to molecular descriptor calculations. Match Commun Math Comput Chem 56:237–48
   Web of Science ®Google Scholar
• Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, et al. 2006. Safe handling of nanotechnology. Nature 444:267–9
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE. 2013. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett 220:286–93
   PubMed Web of Science ®Google Scholar
• Monti S, Tamayo P, Mesirov J, Golub T. 2003. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52:91–118
   Web of Science ®Google Scholar
• Mu Q, Jiang G, Chen L, Zhou H, Fourches D, Tropsha A, Yan B. 2014. Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev 114:7740–81
   PubMed Web of Science ®Google Scholar
• Mu Q, Liu W, Xing Y, Zhou H, Li Z, Zhang Y, et al. 2008. Protein binding by functionalized multiwalled carbon nanotubes is governed by the surface chemistry of both parties and the nanotube diameter. J Phys Chem B 112:3300–7
   PubMed Web of Science ®Google Scholar
• Murray AR, Kisin E, Inman A, Young S-H, Muhammed M, Burks T, et al. 2012. Oxidative stress and dermal toxicity of iron oxide nanoparticles in vitro. Cell Biochem Biophys 67:461–76
   Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater 8:543–57
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–7
   PubMed Web of Science ®Google Scholar
• Puzyn T, Leszczynska D, Leszczynski J. 2009. Toward the development of “nano-QSARs”: advances and challenges. Small 5:2494–509
   PubMed Web of Science ®Google Scholar
• Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, Michalkova A, et al. 2011. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 6:175–8
   PubMed Web of Science ®Google Scholar
• Qu G, Bai Y, Zhang Y, Jia Q, Zhang W, Yan B. 2009. The effect of multiwalled carbon nanotube agglomeration on their accumulation in and damage to organs in mice. Carbon NY 48:2060–9
   Web of Science ®Google Scholar
• Rodgers AD, Zhu H, Fourches D, Rusyn I, Tropsha A. 2010. Modeling liver-related adverse effects of drugs using knearest neighbor quantitative structure–activity relationship method. Chem Res Toxicol 23:724–32
   PubMed Web of Science ®Google Scholar
• Savolainen K, Pylkkänen L, Norppa H, Falck G, Lindberg H, Tuomi T, et al. 2010. Nanotechnologies, engineered nanomaterials and occupational health and safety – a review. Saf Sci 48:957–63
   Web of Science ®Google Scholar
• Service RF. 2004. Nanotoxicology: nanotechnology grows up. Science 304:1732–4
   PubMed Web of Science ®Google Scholar
• Shao C-Y, Chen S-Z, Su B-H, Tseng YJ, Esposito EX, Hopfinger AJ. 2013. Dependence of QSAR models on the selection of trial descriptor sets: a demonstration using nanotoxicity endpoints of decorated nanotubes. J Chem Inf Model 53:142–58
   PubMed Web of Science ®Google Scholar
• Singh KP, Gupta S. 2014. Nano-QSAR modeling for predicting biological activity of diverse nanomaterials. RSC Adv 4:13215–30
   Web of Science ®Google Scholar
• Sips M. 2009. Nanotechnology in perspective risks to man and the environment. Public Health 1:1–138
   Google Scholar
• Su G, Yan B. 2010. Nano-combinatorial chemistry strategy for nanotechnology research. J Comb Chem 12:215–21
   PubMed Web of Science ®Google Scholar
• Toropov AA, Toropova AP, Puzyn T, Benfenati E, Gini G, Leszczynska D, Leszczynski J. 2013. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells. Chemosphere 92:31–7
   PubMed Web of Science ®Google Scholar
• Toropova AP, Toropov AA, Benfenati E, Korenstein R. 2014. QSAR model for cytotoxicity of SiO2 nanoparticles on human lung fibroblasts. J Nanoparticle Res 16:2282–9
   Web of Science ®Google Scholar
• Tropsha A. 2010. Best practices for QSAR model development, validation, and exploitation. Mol Inform 29:476–88
   PubMed Web of Science ®Google Scholar
• Tropsha A, Golbraikh A. 2007. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Curr Pharm Des 13:3494–504
   PubMed Web of Science ®Google Scholar
• Varnek A, Fourches D, Horvath D, Klimchuk O, Gaudin C, Vayer P, et al. 2008. ISIDA – platform for virtual screening based on fragment and pharmacophoric descriptors. Curr Comput Aided Drug Des 4:191–8
   Web of Science ®Google Scholar
• Vilar S, Cozza G, Moro S. 2008. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 8:1555–72
   PubMed Web of Science ®Google Scholar
• Winkler DA, Mombelli E, Pietroiusti A, Tran L, Worth A, Fadeel B, McCall MJ. 2012. Applying quantitative structure–activity relationship approaches to nanotoxicology: current status and future potential. Toxicology 313:15–23
   PubMed Web of Science ®Google Scholar
• Yan B. 2011. Nano-combinatorial and catalyst screening technologies. Comb Chem High Throughput Screen 14:146–54
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bai Y, Jia J, Gao N, Li Y, Zhang R, et al. 2014. Perturbation of physiological systems by nanoparticles. Chem Soc Rev 43:3762–809
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bai Y, Yan B. 2010a. Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today 15:428–35
   PubMed Web of Science ®Google Scholar
• Zhang B, Xing Y, Li Z, Zhou H, Mu Q, Yan B. 2009. Functionalized carbon nanotubes specifically bind to alpha-chymotrypsin’s catalytic site and regulate its enzymatic function. Nano Lett 9:2280–4
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhou H, Yan B. 2010b. Reducing nanotube cytotoxicity using a nano-combinatorial library approach. Methods Mol Biol 625:95–107
   PubMedGoogle Scholar
• Zheng W, Tropsha A. 2000. Novel variable selection quantitative structure–property relationship approach based on the k-nearest-neighbor principle. J Chem Inf Comput Sci 40:185–94
   PubMedGoogle Scholar
• Zhou H, Mu Q, Gao N, Liu A, Xing Y, Gao S, et al. 2008. A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response. Nano Lett 8:859–65
   PubMed Web of Science ®Google Scholar
• Zhu H, Rusyn I, Richard A, Tropsha A. 2008a. Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure–activity relationship models of animal carcinogenicity. Environ Health Perspect 116:506–13
   PubMed Web of Science ®Google Scholar
• Zhu H, Tropsha A, Fourches D, Varnek A, Papa E, Gramatica P, et al. 2008b. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis. J Chem Inf Model 48:766–84
   PubMed Web of Science ®Google Scholar